MedPath

Effects of a Self-Care Promoting Program on preventing and delaying DR severity

Phase 1
Completed
Conditions
The person with type 2 diabetes and diabetic retinopathy in mild, moderate, and severe non-proliferative diabetic retinopathy stages.
Diabetic Retinopathy, Self-Care Program, Type 2 Diabetes, Vision-related quality of life
Registration Number
TCTR20230302002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
98
Inclusion Criteria

1. Have been diagnosed with type 2 DM with received diabetes treatment
2. Have been diagnosed with mild, moderate, or severe NPDR and attending the retinal center of Mettapracharak (Wat Rai Khing) Hospital 3. Age between 30 and 69 years 4. HbA1c is equal to or more than 7 %, at least within the past year before data collection 5. Able to use line application 6. able to speak, read, and write the Thai language 7. Agree to be in this study.

Exclusion Criteria

1. Blood pressure level over 140/90 mmHg, total cholesterol (TC) equal to or more than 240 mg/dl, and low-density lipoprotein-cholesterol (LDL-C) equal to or more than 160 mg/dl within the past year before data collection 2. BMI equivalent or more than 30 kg/m2 3.Severe diabetes complications or other serious conditions that make them unable to complete the program due to advanced illnesses such as heart failure, receiving hemodialysis, or experiencing a diabetic crisis such as end-stage renal disease (ESRD). 4. Have diabetic macular edema (DME) and Proliferative Diabetic Retinopathy (PDR) 5. Mature cataracts.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Engagement in Self-care behaviors, HbA1c, VA, Sevirity of DR, and vision-related quality of life basedline, 8, 16 weeks 1.Self-Care of Diabetes Index questionaires (SCODI) 2. Impact of Visual Impairment questionaires (IVI) 3. Blood test for HbA1C 4. Patient's retinal images for grading severity of DR 5. VA Log Mar
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath